Applied BioMath (www.appliedbiomath.com), the industry-leader in applying mechanistic modeling to drug development, has been named a Top 10 small, high growth business in the Greater Boston area by the Greater Boston Chamber of Commerce. This award honors businesses that demonstrate achievement in management, workplace excellence, product innovation, and social responsibility.
In The News
Applied BioMath (www.appliedbiomath.com), the industry-leader in applying mechanistic modeling to drug development, today announced their participation in the SIAM Conference on the Life Sciences which was held July 11-14, 2016 in Boston, MA.
Dr. John Burke, Co-Founder, President, and CEO of Applied BioMath, LLC was recently featuerd in CEO/CFO magazine. Lynn Fosse, Senior Editor of CEOCFO Magazine interviewed Dr. Burke to learn about how Applied BioMath is revolutionizing drug invention, why its technology is different than anything offered today, and examples where Applied BioMath helped optimize and accelerate drug development.
Applied BioMath, LLC expands QSP-SB Industry and Academia Symposium to include poster session sponsored by Pfizer Inc.
Applied BioMath, LLC announces live webinar on Quantitative Systems Pharmacology Modeling (QSPM) in Immuno-oncology
Applied BioMath's Scientific and Executive Leadership Teams recently spent the day at our Science and Strategy offsite. We reflected on 2015 projects, shared new science and technologies, and officially kicked off 2016. We are extremely proud of what we achieved in 2015, and we will work diligently to continue that momentum into and throughout 2016!
Dr. Joseph Loscalzo, MD, PhD announced as newest member of the Applied BioMath Scientific Advisory Board
Top Pharma and Biotech Researchers meet with local Academics for QSP-SB Industry & Academia Symposium
This publication appears in the October 2015 edition of Molecular Cancer Therapeutics